Alectinib,a novel ALK inhibitor
LI Da-wei;LIU Zheng-ping;ZHANG Jian-qiang;Shandong Academy of Pharmaceutical Sciences;Shandong Provincinal Key Laboratory of Biopharmaceuticals;Shandong Freda Co.;Ltd.;Shandong Provincinal Key Laboratory of Mucosal and Transdermal Drug Delivery Technology;

..............page:1561-1565

di er jie quan guo shi pin yao pin an quan yu jian guan bo shi hou lun tan (the 2^nd national food and drug administration post-doctoral forum) zheng wen tong zhi

..............page:1565

Evaluation of pharmaceutical industry structure optimization in China
LUO Wen-hua;SUN Li-hua;ZHOU Jing;Shenyang Pharmaceutical University;Zhejiang Pharmaceutical College;

..............page:1566-1571

Enlightenment of the implementation of DMF notification system in America for pharmaceutical packaging administration system reform in China
LIU Dong;WEI Jing;College of Business Administration;Shenyang Pharmaceutical University;Liaoning Center for Certification of Drug;

..............page:1572-1576

On the expression of prescription in the instruction of traditional Chinese medicine
HAN Wei;ZHOU Yue-hua;Center for Drug Evaluation;China Food and Drug Administration;

..............page:1577-1580

Effect of( R,R)-penehyclidine fumarate on cardiovascular function and body temperature in conscious Beagle dogs
PENG Hui;GUO Jia-bin;YUAN Hai-tao;ZHANG Ting-fen;HE Xiu-shu;ZHONG Bo-hua;ZHANG Gao-kui;WANG Yi-mei;PENG Shuang-qing;Evaluation and Research Center for Toxicology;Institute of Disease Control and Prevention;AMMS;Institute of Pharmacology and Toxicology;AMMS;Greener Pastures Biological Pharmaceutical Co.;Ltd.;

..............page:1581-1586

Safety pharmacology of esculin,a cracking agent of advanced glycation end products
ZHANG Hui-fang;CHEN Yu-cai;WANG Dan-shu;YUAN Tian-yi;WANG Yue-hua;FANG Lian-hua;DU Guan-hua;Beijing Key Laboratory of Drug Targets Identification and Drug Screening;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;

..............page:1587-1594

Progress in research and application of Sendai virus vector
FU Zhi-hao;LI Yong-hong;GAO Kai;RAO Chun-ming;WANG Jun-zhi;National Institutes for Food and Drug Control;

..............page:1595-1599

Progress in pharmacokinetic studies of tyrosine kinase inhibitors
ZHANG Shi;WANG Ming-xia;FENG Zhang-ying;Fourth Hospital of Hebei Medical University;

..............page:1600-1607

Progress in research of total synthesis and formulation of gossypol
YANG Fei-fei;TANG Lu-hong;School of Pharmaceutical Science;Jiangnan University;

..............page:1608-1612

Application progress of eudragit nanoparticles
WANG Jie-min;WANG Xiong-fei;WANG Jiao;WANG Jing;CAO De-ying;Department of Pharmaceutics;College of Pharmacy;Hebei Medical University;

..............page:1613-1616

Recombinant human erythropoietin promotes healing of incisions and anemia in the postoperated patients with gout
SHI Ying-xu;YANG Rui-fei;YANG Bo;MENG Hong-zheng;GUO Xiao-dong;YANG Mao-wei;Department of Orthopedics;the First Hospital of China Medical University;Department of Rehabilitation Therapy;Shenyang Medical College;Department of Orthopedics;the Ninth People’s Hospital of Shenyang;

..............page:1617-1621

A randomized,double-blind,double simulation-controlled,and multi centre trial of Jieyu capsule in the treatment of mild and moderate depression
WANG Hong-yan;XU Ke;ZHANG Hong-yan;Phychiatric Hospital of Taiyuan City;The Sixth Hospital Affiliated to Peking University;Peking University Institute of Mental Health;Key Laboratory of Mental Health;Ministry of Health;

..............page:1622-1625

Bioequivalence studies for solid products of the oral drugs with narrow therapeutic index
DENG Ming;LIU Hui-chen;Department of Clinical Pharmacology;Aerospace Center Hospital;

..............page:1626-1629

Introduction of Guidance for Industry Bioequivalence Recommendations for Specific Products issued by the US Food and Drug Administration
LIU Qian;NAN nan;ZHU Feng-chang;CAO Xiu-ping;DING Li-xia;XU Ming-di;National Institutes for Food and Drug Control;Chinese Pharmaceutical Association;

..............page:1630-1635

A comparison of in vitro dissolution profiles of lurasidone hydrochloride orally disintegrating tablets and conventional tablets
ZHU Qiang;LIU Lang;ZHANG Qi-yu;ZHENG Qiang;KE Xiao;Chengdu Kanghong Pharmaceuticals Group Co.;Ltd.;

..............page:1636-1640

UPLC fingerprints of freeze-dried Xueshuantong for injection
LI Xue-lin;LI Yu-hui;TANG Jin-fa;MENG Xiang-le;LI Wei-xia;ZHAO Ya;CAO Ying-jie;Henan University of Traditional Chinese Medicine;Department of Pharmacy;the First Affiliated Hospital of Henan University of Traditional Chinese Medicine;

..............page:1641-1646

Compatible stability of Danhong injection mixed with vitamin B₆ injection
ZHAO Ya;TANG Jin-fa;ZHANG Hui;LI Wei-xia;CAO Ying-jie;MENG Xiang-le;LI Xue-lin;The First Affiliated Hospital of Henan University of TCM;

..............page:1647-1651

Nintedanib ameliorates lipoplysaccharide-induced lung fibrosis in acute respiratory distress syndrome
HUANG Gui-chuan;LIU Dai-shun;WU Kai-feng;ZHANG Wei;GONG Ling;ZHU Hong-lan;TANG Hong-bo;ZHONG Cheng-yao;Department of Pulmonary Medicine;the Third Affiliated Hospital of Zunyi Medical College;Department of Laboratory Medicine;the Third Affiliated Hospital of Zunyi Medical College;

..............page:1652-1659

di er jie nan bu di qu du xing bing li zhuan ti yan tao hui cheng gong ju ban jing yan jie shao

..............page:1659

Repeated dose toxicity study and strategies for safety assessment of compound Yizhihao particles in juvenile rats
WANG Yong;WANG Rong;LUO Yong-wei;LENG Ying-li;WANG Jing;ZHOU Li;SUN Zu-yue;Department of Pharmacology and Toxicology;Shanghai Institute of Planned Parenthood Research;National Evaluation Center for the Toxicology of Fertility Regulation Drugs;Xinjiang Yinduolan Uighur Medicine Co.;Ltd.;

..............page:1660-1666

Medication therapy management for outpatients with chronic kidney disease
CHEN Shi-di;ZHAO Rong-sheng;Department of Pharmacy;Third Hospital;Peking University;School of Pharmaceutical Sciences;Peking University;

..............page:1667-1672

Safety of zoledronic acid injection in the treatment of osteoporosis
REN Xiao-lei;ZHAN Yi-qiu;LIU Yi;ZHANG Hai-ying;ZHANG Chun-yan;FENG Wan-yu;Department of Pharmacy;People’s Hospital;Peking University;

..............page:1673-1676

Adverse drug reactions induced by sitagliptin:an analysis of domestic and foreign literature
CHENG Jun;Pharmaceutical Affair Office;the Third People’s Hospital Bengbu;

..............page:1677-1680